Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
More articles/Ad
More articles/Ad
More articles
-
Reverse Yankee issuer finds warm reception for €3.5bn four part deal -
Issuer opens books while simultaneously warning on negative impact of soaring costs
-
Industrial gases company latest to try its luck on traditionally quiet day
-
Two US banks have removed any semblance of doubt around working from home. But will the rest of the community follow?
-
New shares were offered at a premium and mostly taken by an external investor in the unusual capital increase
-
PE firm Quadria is looking to trim its stake in the Indian biopharmaceutical company
